Corporate Profile Events and Conferences Our Products Careers Contact Us Site Map
VIOKASE® (pancrelipase, USP) is a pancreatic enzyme concentrate of porcine origin containing standardized lipase, protease, and amylase as well as other pancreatic enzymes. VIOKASE® is available in tablet dosage form for oral administration.
The enzyme potencies of the tablets are:
| VIOKASE® 8 Tablet | VIOKASE® 16 Tablet | |
|
Lipase, USP Units |
8,000 |
16,000 |
|
Protease, USP Units |
30,000 |
60,000 |
|
Amylase, USP Units |
30,000 |
60,000 |
The natural digestive enzymes in VIOKASE® hydrolyze fats into fatty acids and glycerol, split protein into amino acids, and convert carbohydrates to dextrins and short chain sugars.
VIOKASE® (pancrelipase, USP) is indicated in the treatment of exocrine pancreatic insufficiency as associated with but not limited to cystic fibrosis, chronic pancreatitis, pancreatectomy, or obstruction of the pancreas ducts.
For information on the distribution of Axcan products in the United States, please contact:
Roddie Thurman
Manager, Customer Service
Tel: (800) 950-8085
Fax: (205) 991-8426
Contact Customer Service
